ARL15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.42339999681585E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.721480E-03 |
Normal-vs-Stage2 |
1.652480E-02 |
Normal-vs-Stage3 |
3.0626001734646E-10 |
Normal-vs-Stage4 |
7.19246884273161E-12 |
Stage1-vs-Stage2 |
3.533200E-01 |
Stage1-vs-Stage3 |
4.36199999997999E-06 |
Stage1-vs-Stage4 |
1.38850000053203E-07 |
Stage2-vs-Stage3 |
2.393000E-01 |
Stage2-vs-Stage4 |
7.748300E-02 |
Stage3-vs-Stage4 |
2.501600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.34530000028832E-07 |
Normal-vs-AfricanAmerican |
1.86538999999986E-05 |
Normal-vs-Asian |
8.760100E-03 |
Caucasian-vs-AfricanAmerican |
2.439600E-01 |
Caucasian-vs-Asian |
5.477800E-01 |
AfricanAmerican-vs-Asian |
8.875400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.02759999953683E-07 |
Normal-vs-Female |
1.1019000000223E-06 |
Male-vs-Female |
8.973400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.701690E-02 |
Normal-vs-Age(41-60Yrs) |
6.21829999999379E-05 |
Normal-vs-Age(61-80Yrs) |
8.94700002973536E-09 |
Normal-vs-Age(81-100Yrs) |
1.98200000001147E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.271400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.183600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.583200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.116030E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.659700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.939800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.814600E-01 |
Normal-vs-Grade 2 |
8.015300E-03 |
Normal-vs-Grade 3 |
1.73219993904183E-10 |
Normal-vs-Grade 4 |
1.6805445923751E-12 |
Grade 1-vs-Grade 2 |
4.733800E-02 |
Grade 1-vs-Grade 3 |
1.280390E-02 |
Grade 1-vs-Grade 4 |
2.523200E-03 |
Grade 2-vs-Grade 3 |
2.01219999999003E-05 |
Grade 2-vs-Grade 4 |
3.68469998957011E-09 |
Grade 3-vs-Grade 4 |
4.938100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.138700E-03 |
Normal-vs-ccB subtype |
3.10850000184715E-08 |
ccA subtype-vs-ccB subtype |
2.001400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.92639999996302E-06 |
Normal-vs-N1 |
1.01960000442602E-08 |
N0-vs-N1 |
8.375500E-04 |
|
|